Getting Great Science to Market
Lessening the Burden of Type 1 Diabetes with Innovative Cell Therapies
By: Manasi Sinha Jaiman, M.D., M.P.H., Vice President, Clinical Development Imagine an 18-year-old walking into my office. She is looking forward to graduation. Feeling the thrill of receiving that college acceptance letter. Planning gatherings with friends for summer before heading away to school. Then I deliver the diagnosis – Type 1 diabetes (T1D): That patient’s…
Read More
Investigators at Brigham and Women’s Hospital take active role in ACTIV-4
The COVID-19 virus has taken over life as we know it, creating a novel environment for science in which collaboration is key and extraordinary speed is expected without sacrificing accuracy. Funded through Operation Warp Speed, the National Institutes of Health (NIH) launched the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership back in April.…
Read More
Drug Delivery Directly to the Tumor
Historically, scientists have thought of cancer cells as a clone army—since they are all genetically identical, they are universally bad actors. “What we’ve learned since then is that they are more like special forces,” says David Ting, MD, Assistant Physician at the Mass General Cancer Center and Assistant Professor of Medicine at Harvard Medical School.…
Read More
Digital Disease Management
The need for better ways to manage chronic diseases is clear. According to the Centers for Disease Control, chronic diseases are the leading cause of death and disability and a leading driver of the nation’s $3.3 trillion in healthcare costs. While initially promising, telehealth—the use of telecommunications to enhance patient care and promote disease prevention—hasn’t…
Read More
Innovators in Offices Getting Coffee
Innovation and entrepreneurship abound throughout Partners HealthCare, led by world-class investigators and research team members such as you, who work every day to turn ideas into solutions for patients and clinicians around the world. To further this spirit of invention and provide some practical commercialization advice and instruction from some of PHS’ most prolific inventors…
Read More
Disseminating Medical Expertise to Areas that Need it Most
Replacing physicians has been cited as an aim of artificial-intelligence-based approaches to health care. Yet beyond the hype and hyperbole, there is a much more likely — and worthy — application of AI to medicine: infusing clinical expertise into regions where doctors are in short supply. A key case in point: the global shortage of…
Read More
FIRST LOOK: Identification of Healthcare Risks in COPD Patients Using CT and X-ray Images
Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory conditions that affects more than 22 million Americans; it has climbed to be the third leading cause of death and accounts for $32 billion in associated healthcare cost. https://www.youtube.com/watch?v=lLkXqGk8bIM COPD remains underdiagnosed, and its associated comorbidities include cardiovascular disease, musculoskeletal disorders, and lung…
Read More
CRISPR and ZFN, Two Promising Gene-Editing Platforms
Though the underlying mechanism is said to have been initially discovered in 1987, the potential to use CRISPR/Cas9 (“CRISPR”) as a gene editing therapy has recently enthralled the media since its first application in 2013[1]; touting its “blockbuster” potential to “revolutionize” modern medicine as we know it. While the application of this underlying biological mechanism…
Read More
Getting Back to Face Time: AI Tools that Help Reduce Physicians’ Computer Use
Just as computers have propelled major advances in modern medicine, their presence has also become a significant burden. That’s because the amount of time physicians now spend on the computer — reviewing clinical data and completing required documentation in electronic health records (EHRs) — has soared. It is estimated that physicians spend roughly half of…
Read More
Minimizing the Threats of Antimicrobial Resistance and Infections Associated with Antibiotic Use
The introduction of effective antibiotics in the 1940s ushered in an era of optimism with rapid declines in deaths due to infections. Since that time, however, antibiotic resistance has emerged rapidly, and too few antibiotics are making it through the development pipeline. That means once curable infections could soon become more virulent and even untreatable.…
Read More
FIRST LOOK: Surgical Fingerprints: Real-time Analysis of Intraoperative Events
Intraoperative adverse events (IAEs), such as bowel/vascular injury, are estimated to occur in 2% of operations. IAEs can exact a toll on patient quality of life and costs, with average admission charges estimated to be 41% higher for patients who experience IAEs. Up to two-thirds of surgical errors occur intraoperatively, and 86% of these are…
Read More
Harnessing the Power of Digital Pathology
Through its decades-long practice of digitizing clinical images, radiology is providing an early proving ground for machine learning-based approaches for disease detection, diagnosis, and prognosis. With a vast, rich pool of radiological images, researchers have access to the raw material needed to develop and hone new disease-detection algorithms, which are helping to drive the AI…
Read More
Bringing “Smart” Machines to Medicine
Self-driving cars are poised to disrupt the transportation industry, and there is a similar revolution underway in health care. This effort seeks to engineer a new generation of “smart” medical equipment that melds scanning with interpretation, monitoring with treatment, and merges data from disparate devices into a common, readily interpretable stream. The goal: to help…
Read More
Copyright 101: learn how to protect your creative works.
What: Copyrights protect original works of authorship fixed in a tangible medium of expression and this really speaks to what kinds of things are “eligible” for copyright protection. But to put it more simply, copyrights protect the expression of ideas. If we want to have a firm grasp of what copyrights really are, we’re going…
Read More
Reading the Tea Leaves of Cancer Immunotherapy
The immune system protects the body from a host of foreign invaders. Over the last few years, therapies that leverage these defenses to fight cancer — so-called cancer immunotherapies — have yielded impressive outcomes in combating some forms of the disease. Yet as promising as these therapies are, they currently help only a small subset…
Read More
FIRST LOOK: bloodTyper: Blood Group Typing using Next Generation Sequencing
Blood transfusion is one of the most common therapies administered in US hospitals, but sensitization to red blood cell (RBC) and platelet (PLT) antigens can lead to serious complications in prenatal medicine and transfusion. Although there are over 300 known RBC and 33 PLT antigens, current testing only includes matching the patient and donor for…
Read More
FIRST LOOK: Leveraging Machine Learning for Personalized Cancer Treatments
It is not obvious how decades of hard won biological knowledge can be incorporated into building machine learning algorithms for predicting how a drug will affect a patient. We study this problem from theoretical, computational, and practical angles. Click here to watch Dr. Craft’s First Look presentation. Our computational studies provide strong evidence that incorporating…
Read MoreFrom Innovation to Commercialization – Bridging the Gap
In a world where science, technology, and innovation run parallel to the entrepreneurial spirit, a bridge is often needed to connect expertise, knowledge and wisdom to the lifesaving inventions that patients need most. That’s why we launched the BRIDGES blog. Launched in December 2017, BRIDGES is a collaborative resource where Innovation staff, technology experts, investors,…
Read MorePrinted from https://innovationblog.partners.org/lessening-the-burden-of-type-1-diabetes-with-innovative-cell-therapies · Published 06 May 2021
© Mass General Brigham Incorporated. All rights reserved.